Royalty Pharma Plc (RPRX) reported its Q4 2024 earnings today, revealing earnings per share (EPS) of $0.3531, falling short of the forecasted $0.9849. The company also reported revenue of $594 million ...

S&P Global posted strong earnings for Q4 2024, significantly surpassing market expectations with robust growth in its Ratings ...

Arvinas Inc. (ARVN) reported its earnings for the fourth quarter of 2024, revealing a smaller-than-expected loss per share ...

China’s tablet market experienced a resurgence in 2024, with shipments reaching 29.85 million units, a 4.3% year-on-year ...

Exodus Movement (NYSEAMERICAN: EXOD) is a cryptocurrency wallet platform. It is self-custodial and supports 369 cryptocurrencies, so it is very popular in the crypto community. It also allows people ...

The brand takes the cake for the first time ever. According to Canalys, Oppo has for the first time outsold all of its ...

Coca-Cola showcased its ability to boost earnings despite challenges, with a robust Q4 2024 performance led by product and ...

Strong growth in domestic tractor sales in January FY25, with Mahindra leading; positive outlook for Q4 industry expansion.

Strong growth in domestic tractor sales in January FY25, with Mahindra leading; positive outlook for Q4 industry expansion.

We project that consolidated gross margin for the fourth quarter of 2024 will be in the low 40s, compared to our guidance of 'in the high 30% range'. This reflects the stronger than projected rebound ...

For full year 2024, Royalty Pharma announced new transactions of up to approximately $2.8 billion. The announced transactions amount reflects the entire amount of capital committed for new ...

The global smartphone market grew by 7.1% in 2024, with Xiaomi leading in growth while Apple and Samsung faced slight declines.